Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on April 9, 2020, covering events that occurred on April 8, 2020. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Salt Lake City, Utah.
Key Financial Metrics
The filing does not provide standard operating metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial event reported is a capital raise:
- Convertible Senior Notes: The Company priced an offering of $200 million principal amount of convertible senior notes due 2025.
- Initial Proposal: The offering was initially proposed at $175 million principal amount.
- Regulation: The notes were issued pursuant to Rule 144A under the Securities Act of 1933.
Material Changes
The material change reported is the execution of a private debt offering. The Company increased the principal amount of the offering from the initially proposed $175 million to a final priced amount of $200 million on the same day.
Guidance, Outlook, and Risks
This filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the debt offering. The filing serves to disclose the transaction details and incorporates press releases as exhibits.
Investor Verification Checklist
- Verify the final terms of the $200 million convertible senior notes due 2025 in the accompanying press release (Exhibit 99.2).
- Confirm the conversion rate and interest rate associated with the new debt instrument.
- Review the Company's most recent 10-K or 10-Q to assess the impact of this new debt on total leverage and liquidity.
- Check for any subsequent filings regarding the use of proceeds from this offering.